182 related articles for article (PubMed ID: 32693607)
1. Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer.
You L; Fan Y; Liu X; Shao S; Guo L; Noreldeen HAA; Li Z; Ouyang Y; Li E; Pan X; Liu T; Tian X; Ye F; Li X; Xu G
J Proteome Res; 2020 Sep; 19(9):3750-3760. PubMed ID: 32693607
[TBL] [Abstract][Full Text] [Related]
2. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
3. Lipid alterations and subtyping maker discovery of lung cancer based on nontargeted tissue lipidomics using liquid chromatography-mass spectrometry.
Fan Y; Noreldeen HAA; You L; Liu X; Pan X; Hou Z; Li Q; Li X; Xu G
J Pharm Biomed Anal; 2020 Oct; 190():113520. PubMed ID: 32784094
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.
Wikoff WR; Grapov D; Fahrmann JF; DeFelice B; Rom WN; Pass HI; Kim K; Nguyen U; Taylor SL; Gandara DR; Kelly K; Fiehn O; Miyamoto S
Cancer Prev Res (Phila); 2015 May; 8(5):410-8. PubMed ID: 25657018
[TBL] [Abstract][Full Text] [Related]
7. Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry.
Mu Y; Zhou Y; Wang Y; Li W; Zhou L; Lu X; Gao P; Gao M; Zhao Y; Wang Q; Wang Y; Xu G
J Proteome Res; 2019 May; 18(5):2175-2184. PubMed ID: 30892048
[TBL] [Abstract][Full Text] [Related]
8. Development of LC-QTOF-MS method for human lung tissue fingerprinting. A preliminary application to nonsmall cell lung cancer.
Ciborowski M; Kisluk J; Pietrowska K; Samczuk P; Parfieniuk E; Kowalczyk T; Kozlowski M; Kretowski A; Niklinski J
Electrophoresis; 2017 Sep; 38(18):2304-2312. PubMed ID: 28440547
[TBL] [Abstract][Full Text] [Related]
9. Combined metabolomics with transcriptomics reveals potential plasma biomarkers correlated with non-small-cell lung cancer proliferation through the Akt pathway.
Zheng J; Zheng Y; Li W; Zhi J; Huang X; Zhu W; Liu Z; Gong L
Clin Chim Acta; 2022 May; 530():66-73. PubMed ID: 35245482
[TBL] [Abstract][Full Text] [Related]
10. Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection.
Li J; Liu K; Ji Z; Wang Y; Yin T; Long T; Shen Y; Cheng L
Cancer Sci; 2023 Feb; 114(2):680-689. PubMed ID: 36310111
[TBL] [Abstract][Full Text] [Related]
11. Non-Small Cell Lung Cancer Detection and Subtyping by UPLC-HRMS-Based Tissue Metabolomics.
Zang X; Zhang J; Jiao P; Xue X; Lv Z
J Proteome Res; 2022 Aug; 21(8):2011-2022. PubMed ID: 35856400
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites.
Yue X; He J; Zhang R; Xu J; Zhou Z; Zhang R; Bi N; Wang Z; Sun C; Wang L; Chen Y; Abliz Z
J Chromatogr A; 2018 Dec; 1580():80-89. PubMed ID: 30473010
[TBL] [Abstract][Full Text] [Related]
14. UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.
Wang Y; Wang CH; Zhang YF; Zhu L; Lei HM; Tang YB
Metabolomics; 2019 Mar; 15(4):52. PubMed ID: 30911937
[TBL] [Abstract][Full Text] [Related]
15. Metabolic signatures of four major histological types of lung cancer cells.
Lim SL; Jia Z; Lu Y; Zhang H; Ng CT; Bay BH; Shen HM; Ong CN
Metabolomics; 2018 Aug; 14(9):118. PubMed ID: 30830374
[TBL] [Abstract][Full Text] [Related]
16. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
[TBL] [Abstract][Full Text] [Related]
17. [Research Progress on Tumor Metabolic Biomarkers in Liquid Biopsy of Lung Cancer].
Zou S; Li N; Zhang T; Geng Q
Zhongguo Fei Ai Za Zhi; 2024 Feb; 27(2):126-132. PubMed ID: 38453444
[TBL] [Abstract][Full Text] [Related]
18. Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer.
Shen Y; Sun M; Zhu J; Wei M; Li H; Zhao P; Wang J; Li R; Tian L; Tao Y; Shen P; Zhang J
Mol Omics; 2021 Jun; 17(3):464-471. PubMed ID: 33881127
[TBL] [Abstract][Full Text] [Related]
19. Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics.
Klupczynska A; Dereziński P; Garrett TJ; Rubio VY; Dyszkiewicz W; Kasprzyk M; Kokot ZJ
J Cancer Res Clin Oncol; 2017 Apr; 143(4):649-659. PubMed ID: 28168355
[TBL] [Abstract][Full Text] [Related]
20. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
